NEW YORK (GenomeWeb) – Waters today reported that its revenues in the third quarter were up 7 percent year over year, driven by solid demand across the company's end markets including particularly strong sales to government and academic customers.

The company posted revenues of $565.6 million, up from $526.8 million in Q3 2016, and beating the average Wall Street estimate of $553.2 million. Waters said that foreign currency translation boosted sales growth by around 1 percent in the quarter.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.